Navigation Links
MiddleBrook Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
Date:3/14/2008

Presentation will be webcast live and archived on Company's web site

GERMANTOWN, Md., March 14 /PRNewswire-FirstCall/ -- MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that Dr. Edward M. Rudnic, MiddleBrook president and CEO, will deliver a corporate presentation on Tuesday, March 18, 2008, at 4:45 p.m. Eastern Time.

The presentation will take place as part of the Lehman Brothers Eleventh Annual Global Healthcare Conference at the Loews Miami Beach Hotel in Miami Beach, Florida. Dr. Rudnic's remarks will be available live on the MiddleBrook web site, where they also will be archived for 30 days.

To access the presentation, log on to http://www.middlebrookpharma.com and click on the Presentations option in the Investor Relations section. Please connect to the web site several minutes prior to the start of the live presentation to ensure adequate time for any software download that may be necessary.

About MiddleBrook Pharmaceuticals:

MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK) is a pharmaceutical company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease. The Company is developing anti-infective drugs based on its novel biological finding that bacteria exposed to antibiotics in front- loaded st
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiddleBrook Pharmaceuticals Closes Private Placement of Common Equity Raising $21 Million
2. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
3. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
4. MiddleBrook Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results
5. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
8. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
9. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
10. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
11. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2008)... BOULDER, Colo., Oct. 15 /- Bolder Bi... awarded a $1.6 million Phase II Continuing,Renewa... entitled,"Long-Acting Beta Interferon for Multipl...logical Disorders and Stroke (NINDS) of The Nation...re grant award is contingent,upon the achievement ...
(Date:10/15/2008)...onference call and webcast to begin after markets ...(5:00 p.m. ET), IRVINE, Calif., Oct. 15 /PRNewswi... ), the inventor of Pulse CO-Oximetry and,Measure-...today announced,it will release third quarter fina...008 after the market closes on Monday, October 27,...
(Date:10/15/2008)... OLDSMAR, Fla., Oct. 15 /- ... CCEL) (the "Company"), one of the,world,s largest...ay,announced results for the third quarter and nin...enues for the third quarter were approximately $4....or the third quarter of,2007. The Company reported...
(Date:10/15/2008)... TORONTO, Oct. 15 / GeneNew...ing blood-based biomarker tests for the early,dete...nt, today announced,that it has appointed Patrick ...ommercial launch of ColonSentry(TM), the world,s f...nt risk for colorectal cancer. Mr. Terry,is one of...
Breaking Biology Technology:Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug 2Masimo to Report Third Quarter 2008 Financial Results on October 27, 2008 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 4Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 5Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 6GeneNews appoints Patrick Terry as lead strategic advisor for U.S. commercialization of ColonSentry(TM) 2
... ,Study protein function more efficiently with s...Heidi Davis David T. Wong ,Kelly Wynne Vilma N...Sorge Edward Marsh ,Stratagene , Spencer Stev..., Stratagene now offers sequence-validated and ex...ression vector. These clones eliminate the time sp...
..., Miniprep and midiprep quantities of pure high-...tagene , The StrataPrep plasmid miniprep and m...d 350 g, respectively, of high-purity plasmid,DN... easily purify very,large plasmids, including co...tion, a SuperCos I clone containing a 40-kb , ...
..., Novel pdual expression vector for high-level e... , Kerstien A. Padgett Joseph A. Sorge ,St...pression vector,* which permits,high-level expre... prokaryotic,systems. The vector contains the pr...lovirus (CMV) immediate early gene for constitutiv...
..., Investigating programmed cell death , We...,Pingerelli ,Stratagene , The apoptotic respo...the,regulation of a variety of genes that intera...llular stimuli. Stratagene is introducing RT-PCR p...ed in inducing and regulating the,apoptotic resp...
Other Biology Technology:Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 2Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 3Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 4Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 5Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression,Vector 6Easy Cosmid DNA Purification with StrataPrep Kits 2Mammalian and Bacterial Expression in One Vector 2Mammalian and Bacterial Expression in One Vector 3Mammalian and Bacterial Expression in One Vector 4Mammalian and Bacterial Expression in One Vector 5Mammalian and Bacterial Expression in One Vector 6RT-PCR Primers for the Study of Apoptosis 2RT-PCR Primers for the Study of Apoptosis 3RT-PCR Primers for the Study of Apoptosis 4RT-PCR Primers for the Study of Apoptosis 5RT-PCR Primers for the Study of Apoptosis 6RT-PCR Primers for the Study of Apoptosis 7
(Date:10/15/2008)...enter (SDSC) at the University of California, San ...called the Triton Resource, a high-impact, massive...rate innovation, collaboration, and discovery thro...ucture at SDSC. , SDSC is leading the effort to ... and UC San Diego researchers. Specific details o...
(Date:10/15/2008)... during its embryonic/fetal development, it can re... functional by birth, provided some of the heart c...the Max Delbrck Center for Molecular Medicine (MDC...lleagues from Australia. They were able to demonst...heart divide more frequently and thus displace the...
(Date:10/14/2008)...the University of Idaho currently are involved in ... been running rampant for the past decade. But the...nted list. Instead, it,s on the minds of ecologist... Batrachochytrium dendrobatidis (Bd). It is a "c...otein found in the skin of amphibians, and is part...
(Date:10/14/2008)...n the last decade, biomedical and research breakth...elped transform the care of children, improving di...v. 8 and 9, Morgan Stanley Children,s Hospital of ...al Center will host a conference at the Grand Hyat...ine," to exchange the latest advances in genetics,...
Breaking Biology News(10 mins):San Diego Supercomputer Center and UCSD announce 'Triton Resource' 2San Diego Supercomputer Center and UCSD announce 'Triton Resource' 3San Diego Supercomputer Center and UCSD announce 'Triton Resource' 4Repair in the developing heart 2Modern genetics vs. ancient frog-killing fungus 2Modern genetics vs. ancient frog-killing fungus 3Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 2Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 3Innovations in Pediatric Medicine CME conference brings together national pediatrics experts 4AUDIO from Medialink and Kelloggs 3A A Healthy Beginning Every Day 12818 1Lauren Debrauwere Released from Northwestern Memorial Hospital 12815 1Lauren Debrauwere Released from Northwestern Memorial Hospital 12815 2Lauren Debrauwere Released from Northwestern Memorial Hospital 12815 3Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 1Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 2Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 3Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 4Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 5Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 6Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 7Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 8Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 9Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 10Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 11Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results 3540 12Study Finds Variations in Doses of Radiation Therapy 12812 1Study Finds Variations in Doses of Radiation Therapy 12812 2Study Finds Variations in Doses of Radiation Therapy 12812 3
...ringe at the idea, but sperm-producing stem cells ...e lab, and frozen for future use. A team in the Ne...l stem cells from cows and cultured them inside mo...be done for men. "This is a very promising route t...py," Dirk de Rooij of Utrecht University, Netherla...
...mental tuberculosis drug may be effective against ... but could also be the first compound to treat the...eport their results today at the 2006 ASM Biodefen...ompound is the lead has a very different mechanism...reat tuberculosis. We have identified no cross re...
...ones are not associated with an increased risk of ...rst UK study of the relationship between mobile ph...hed online by the BMJ today. , The four year study...hester and the Institute of Cancer Research, Londo...e were not at a greater overall risk of developing...
... seem bigger than life ?big bones, big mysteries. ...s about dinosaurs may come from small ?very small ...chigan State University zoologist Peggy Ostrom. "W...ls, and proteins can tell us about diseases, about...what they ate and who they are related to." , Ost...
Other Biology News:Testes to incubate stem cells 2Experimental TB drug effective against resistant and latent mycobacterium tuberculosis 2Mobile phone use not linked to increased risk of glioma brain tumours 2Next good dinosaur news likely to come from small packages 2
...al Stem Cell Functional Identification Kit contain...n be used for the short-term maintenance, differen...f NSCs into astrocyte, neuron and oligodendrocyte ...ti-human Nestin, mouse anti-human Glial Fibrillary...
Anti-Mouse MIP-1g, Biotin (Polyclonal) (rabbit IgG)
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details.
Request Info
Biology Products: